Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
The Center for Clinical Research
mi
from
Winston-Salem, NC
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
The Center for Clinical Research
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
St. Alexius Medical Center
mi
from
Bismarck, ND
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
St. Alexius Medical Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Cleveland Clinic
mi
from
Cleveland, OH
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
COR Clinical Research
mi
from
Oklahoma City, OK
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
COR Clinical Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Pain Research of Oregon
mi
from
Eugene, OR
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Pain Research of Oregon
mi
from
Eugene, OR
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Affinity Research
mi
from
Portland, OR
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Affinity Research
mi
from
Portland, OR
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Private Practice of Dr. Hasan
mi
from
Allentown, PA
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Private Practice of Dr. Hasan
mi
from
Allentown, PA
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Preferred Primary Care Physicians
mi
from
Uniontown, PA
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Preferred Primary Care Physicians
mi
from
Uniontown, PA
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Partners in Clinical Research, LLC
mi
from
Cumberland, RI
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Partners in Clinical Research, LLC
mi
from
Cumberland, RI
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
University Gastroenterology
mi
from
Providence, RI
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
University Gastroenterology
mi
from
Providence, RI
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Trident Institute of Medical Research, LLC
mi
from
North Charleston, SC
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Trident Institute of Medical Research, LLC
mi
from
North Charleston, SC
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Southeastern Clinical Research
mi
from
Chattanooga, TN
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Southeastern Clinical Research
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Comprehensive Pain Specialists
mi
from
Hendersonville, TN
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Comprehensive Pain Specialists
mi
from
Hendersonville, TN
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Vanderbilt University - Interventional Pain Center
mi
from
Nashville, TN
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Vanderbilt University - Interventional Pain Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Integrity Clinical Research, LLC
mi
from
Savannah, TN
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Integrity Clinical Research, LLC
mi
from
Savannah, TN
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Dallas VA Research Corporation
mi
from
Dallas, TX
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Dallas VA Research Corporation
mi
from
Dallas, TX
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Bexar Clinical Trials, LLC
mi
from
Dallas, TX
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Bexar Clinical Trials, LLC
mi
from
Dallas, TX
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Permian Research Foundation
mi
from
Odessa, TX
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Permian Research Foundation
mi
from
Odessa, TX
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Bexar Clinical Trials, LLC
mi
from
Richardson, TX
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Bexar Clinical Trials, LLC
mi
from
Richardson, TX
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Salt Lake Research, PLLC
mi
from
Salt Lake City, UT
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Salt Lake Research, PLLC
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Digestive and Liver Disease Specialists
mi
from
Norfolk, VA
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Digestive and Liver Disease Specialists
mi
from
Norfolk, VA
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
General Clinical Research Center, Virginia Commonwealth University, North Hospital
mi
from
Richmond, VA
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
General Clinical Research Center, Virginia Commonwealth University, North Hospital
mi
from
Richmond, VA
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Metro Physicians a Division of Wheaton Franciscan Medical Group
mi
from
Milwaukee, WI
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Metro Physicians a Division of Wheaton Franciscan Medical Group
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Clement J. Zablocki VA Medical Center
mi
from
Milwaukee, WI
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Clement J. Zablocki VA Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Health Sciences Center
mi
from
Hamilton,
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Health Sciences Center
mi
from
Hamilton,
Click here to add this to my saved trials
Electromagnetic Treatment For Bone Loss After Forearm Fracture
Feasibility and Dosing Study of Bone Density Changes With and Without PEMF Following Immobilization of the Forearm
Status: Enrolling
Updated:  12/22/2015
Institute for Human Performance/Upstate Medical University
mi
from
Syracuse, NY
Electromagnetic Treatment For Bone Loss After Forearm Fracture
Feasibility and Dosing Study of Bone Density Changes With and Without PEMF Following Immobilization of the Forearm
Status: Enrolling
Updated: 12/22/2015
Institute for Human Performance/Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
A Multicenter, Randomized, Placebo Controlled Study to Assess the Safety and Efficacy of Orally Administered Silymarin Preparation (Legalon®) for the Treatment of Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
Status: Enrolling
Updated:  12/23/2015
Beth Isreal Deaconess Medical Center
mi
from
Boston, MA
Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
A Multicenter, Randomized, Placebo Controlled Study to Assess the Safety and Efficacy of Orally Administered Silymarin Preparation (Legalon®) for the Treatment of Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
Status: Enrolling
Updated: 12/23/2015
Beth Isreal Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
A Multicenter, Randomized, Placebo Controlled Study to Assess the Safety and Efficacy of Orally Administered Silymarin Preparation (Legalon®) for the Treatment of Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
Status: Enrolling
Updated:  12/23/2015
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
A Multicenter, Randomized, Placebo Controlled Study to Assess the Safety and Efficacy of Orally Administered Silymarin Preparation (Legalon®) for the Treatment of Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
Status: Enrolling
Updated: 12/23/2015
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
A Multicenter, Randomized, Placebo Controlled Study to Assess the Safety and Efficacy of Orally Administered Silymarin Preparation (Legalon®) for the Treatment of Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
Status: Enrolling
Updated:  12/23/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
A Multicenter, Randomized, Placebo Controlled Study to Assess the Safety and Efficacy of Orally Administered Silymarin Preparation (Legalon®) for the Treatment of Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
Status: Enrolling
Updated: 12/23/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
A Multicenter, Randomized, Placebo Controlled Study to Assess the Safety and Efficacy of Orally Administered Silymarin Preparation (Legalon®) for the Treatment of Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
Status: Enrolling
Updated:  12/23/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
A Multicenter, Randomized, Placebo Controlled Study to Assess the Safety and Efficacy of Orally Administered Silymarin Preparation (Legalon®) for the Treatment of Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
Status: Enrolling
Updated: 12/23/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
A Multicenter, Randomized, Placebo Controlled Study to Assess the Safety and Efficacy of Orally Administered Silymarin Preparation (Legalon®) for the Treatment of Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
Status: Enrolling
Updated:  12/23/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
A Multicenter, Randomized, Placebo Controlled Study to Assess the Safety and Efficacy of Orally Administered Silymarin Preparation (Legalon®) for the Treatment of Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
Status: Enrolling
Updated: 12/23/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
A Multicenter, Randomized, Placebo Controlled Study to Assess the Safety and Efficacy of Orally Administered Silymarin Preparation (Legalon®) for the Treatment of Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
Status: Enrolling
Updated:  12/23/2015
Brooke Army Medical Center
mi
from
San Antonio, TX
Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
A Multicenter, Randomized, Placebo Controlled Study to Assess the Safety and Efficacy of Orally Administered Silymarin Preparation (Legalon®) for the Treatment of Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
Status: Enrolling
Updated: 12/23/2015
Brooke Army Medical Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
An Exploratory, Phase II Trial to Determine the Association of Lapatinib Induced Fluoropyrimidine Gene Changes With Efficacy Parameters of Lapatinib and Capecitabine in First Line Gastric Cancer
Status: Enrolling
Updated:  12/24/2015
GSK Investigational Site
mi
from
Loma Linda, CA
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
An Exploratory, Phase II Trial to Determine the Association of Lapatinib Induced Fluoropyrimidine Gene Changes With Efficacy Parameters of Lapatinib and Capecitabine in First Line Gastric Cancer
Status: Enrolling
Updated: 12/24/2015
GSK Investigational Site
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
An Exploratory, Phase II Trial to Determine the Association of Lapatinib Induced Fluoropyrimidine Gene Changes With Efficacy Parameters of Lapatinib and Capecitabine in First Line Gastric Cancer
Status: Enrolling
Updated:  12/24/2015
GSK Investigational Site
mi
from
Los Angeles, CA
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
An Exploratory, Phase II Trial to Determine the Association of Lapatinib Induced Fluoropyrimidine Gene Changes With Efficacy Parameters of Lapatinib and Capecitabine in First Line Gastric Cancer
Status: Enrolling
Updated: 12/24/2015
GSK Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
An Exploratory, Phase II Trial to Determine the Association of Lapatinib Induced Fluoropyrimidine Gene Changes With Efficacy Parameters of Lapatinib and Capecitabine in First Line Gastric Cancer
Status: Enrolling
Updated:  12/24/2015
GSK Investigational Site
mi
from
Washington,
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
An Exploratory, Phase II Trial to Determine the Association of Lapatinib Induced Fluoropyrimidine Gene Changes With Efficacy Parameters of Lapatinib and Capecitabine in First Line Gastric Cancer
Status: Enrolling
Updated: 12/24/2015
GSK Investigational Site
mi
from
Washington,
Click here to add this to my saved trials
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
An Exploratory, Phase II Trial to Determine the Association of Lapatinib Induced Fluoropyrimidine Gene Changes With Efficacy Parameters of Lapatinib and Capecitabine in First Line Gastric Cancer
Status: Enrolling
Updated:  12/24/2015
GSK Investigational Site
mi
from
Shreveport, LA
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
An Exploratory, Phase II Trial to Determine the Association of Lapatinib Induced Fluoropyrimidine Gene Changes With Efficacy Parameters of Lapatinib and Capecitabine in First Line Gastric Cancer
Status: Enrolling
Updated: 12/24/2015
GSK Investigational Site
mi
from
Shreveport, LA
Click here to add this to my saved trials
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
An Exploratory, Phase II Trial to Determine the Association of Lapatinib Induced Fluoropyrimidine Gene Changes With Efficacy Parameters of Lapatinib and Capecitabine in First Line Gastric Cancer
Status: Enrolling
Updated:  12/24/2015
GSK Investigational Site
mi
from
Ann Arbor, MI
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
An Exploratory, Phase II Trial to Determine the Association of Lapatinib Induced Fluoropyrimidine Gene Changes With Efficacy Parameters of Lapatinib and Capecitabine in First Line Gastric Cancer
Status: Enrolling
Updated: 12/24/2015
GSK Investigational Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
An Exploratory, Phase II Trial to Determine the Association of Lapatinib Induced Fluoropyrimidine Gene Changes With Efficacy Parameters of Lapatinib and Capecitabine in First Line Gastric Cancer
Status: Enrolling
Updated:  12/24/2015
GSK Investigational Site
mi
from
Southgate, MI
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
An Exploratory, Phase II Trial to Determine the Association of Lapatinib Induced Fluoropyrimidine Gene Changes With Efficacy Parameters of Lapatinib and Capecitabine in First Line Gastric Cancer
Status: Enrolling
Updated: 12/24/2015
GSK Investigational Site
mi
from
Southgate, MI
Click here to add this to my saved trials
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
An Exploratory, Phase II Trial to Determine the Association of Lapatinib Induced Fluoropyrimidine Gene Changes With Efficacy Parameters of Lapatinib and Capecitabine in First Line Gastric Cancer
Status: Enrolling
Updated:  12/24/2015
GSK Investigational Site
mi
from
Jefferson City, MO
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
An Exploratory, Phase II Trial to Determine the Association of Lapatinib Induced Fluoropyrimidine Gene Changes With Efficacy Parameters of Lapatinib and Capecitabine in First Line Gastric Cancer
Status: Enrolling
Updated: 12/24/2015
GSK Investigational Site
mi
from
Jefferson City, MO
Click here to add this to my saved trials
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
An Exploratory, Phase II Trial to Determine the Association of Lapatinib Induced Fluoropyrimidine Gene Changes With Efficacy Parameters of Lapatinib and Capecitabine in First Line Gastric Cancer
Status: Enrolling
Updated:  12/24/2015
GSK Investigational Site
mi
from
Dallas, TX
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
An Exploratory, Phase II Trial to Determine the Association of Lapatinib Induced Fluoropyrimidine Gene Changes With Efficacy Parameters of Lapatinib and Capecitabine in First Line Gastric Cancer
Status: Enrolling
Updated: 12/24/2015
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
An Exploratory, Phase II Trial to Determine the Association of Lapatinib Induced Fluoropyrimidine Gene Changes With Efficacy Parameters of Lapatinib and Capecitabine in First Line Gastric Cancer
Status: Enrolling
Updated:  12/24/2015
GSK Investigational Site
mi
from
Montreal,
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
An Exploratory, Phase II Trial to Determine the Association of Lapatinib Induced Fluoropyrimidine Gene Changes With Efficacy Parameters of Lapatinib and Capecitabine in First Line Gastric Cancer
Status: Enrolling
Updated: 12/24/2015
GSK Investigational Site
mi
from
Montreal,
Click here to add this to my saved trials
Methylnaltrexone for Opioid-induced Constipation in Cancer Patients
Phase II Trial of Subcutaneous Methylnaltrexone in the Treatment of Severe Opioid-induced Constipation in Cancer Patients
Status: Enrolling
Updated:  12/29/2015
Fletcher Allen Health Care
mi
from
Burlington, VT
Methylnaltrexone for Opioid-induced Constipation in Cancer Patients
Phase II Trial of Subcutaneous Methylnaltrexone in the Treatment of Severe Opioid-induced Constipation in Cancer Patients
Status: Enrolling
Updated: 12/29/2015
Fletcher Allen Health Care
mi
from
Burlington, VT
Click here to add this to my saved trials
Treatment of Crohn's Fistula Using a Porcine Intestine Submucosa Graft
Treatment of Crohn's Fistula Using a Porcine Intestine Submucosa Graft (SurgiSIS AFP)
Status: Enrolling
Updated:  12/29/2015
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Treatment of Crohn's Fistula Using a Porcine Intestine Submucosa Graft
Treatment of Crohn's Fistula Using a Porcine Intestine Submucosa Graft (SurgiSIS AFP)
Status: Enrolling
Updated: 12/29/2015
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Treatment of Crohn's Fistula Using a Porcine Intestine Submucosa Graft
Treatment of Crohn's Fistula Using a Porcine Intestine Submucosa Graft (SurgiSIS AFP)
Status: Enrolling
Updated:  12/29/2015
Mount Sinai Hospital
mi
from
New York, NY
Treatment of Crohn's Fistula Using a Porcine Intestine Submucosa Graft
Treatment of Crohn's Fistula Using a Porcine Intestine Submucosa Graft (SurgiSIS AFP)
Status: Enrolling
Updated: 12/29/2015
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Treatment of Crohn's Fistula Using a Porcine Intestine Submucosa Graft
Treatment of Crohn's Fistula Using a Porcine Intestine Submucosa Graft (SurgiSIS AFP)
Status: Enrolling
Updated:  12/29/2015
Univeristy Hospitals Medical Center
mi
from
Cleveland, OH
Treatment of Crohn's Fistula Using a Porcine Intestine Submucosa Graft
Treatment of Crohn's Fistula Using a Porcine Intestine Submucosa Graft (SurgiSIS AFP)
Status: Enrolling
Updated: 12/29/2015
Univeristy Hospitals Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Efficacy of Daily Vitamin D3 Supplementation in Normal Weight Adolescents
A Pilot Study to Evaluate the Efficacy of Daily Vitamin D3 Supplementation in Normal Weight Adolescents
Status: Enrolling
Updated:  12/30/2015
The Mayo Clinic
mi
from
Rochester, MN
Efficacy of Daily Vitamin D3 Supplementation in Normal Weight Adolescents
A Pilot Study to Evaluate the Efficacy of Daily Vitamin D3 Supplementation in Normal Weight Adolescents
Status: Enrolling
Updated: 12/30/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma
A Phase II Study of Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma
Status: Enrolling
Updated:  1/4/2016
Memorial Sloan Kettering Cancer Center
mi
from
Basking Ridge, NJ
Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma
A Phase II Study of Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma
Status: Enrolling
Updated: 1/4/2016
Memorial Sloan Kettering Cancer Center
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma
A Phase II Study of Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma
Status: Enrolling
Updated:  1/4/2016
Memorial Sloan-Kettering Cancer Center
mi
from
Commack, NY
Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma
A Phase II Study of Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma
Status: Enrolling
Updated: 1/4/2016
Memorial Sloan-Kettering Cancer Center
mi
from
Commack, NY
Click here to add this to my saved trials
Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma
A Phase II Study of Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma
Status: Enrolling
Updated:  1/4/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma
A Phase II Study of Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma
Status: Enrolling
Updated: 1/4/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials